BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 810194)

  • 1. Mediators of passive lung anaphylaxis in the rat.
    Farmer JB; Richards IM; Sheard P; Woods AM
    Br J Pharmacol; 1975 Sep; 55(1):57-64. PubMed ID: 810194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the anti-anaphylactic activities of salbutamol and disodium cromoglycate in the rat, the rat mast cell and in human lung tissue.
    Butchers PR; Fullarton JR; Skidmore IF; Thompson LE; Vardey CJ; Wheeldon A
    Br J Pharmacol; 1979 Sep; 67(1):23-32. PubMed ID: 115530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The release of spasmogenic substances from human chopped lung tissue and its inhibition.
    Piper PJ; Walker JL
    Br J Pharmacol; 1973 Feb; 47(2):291-304. PubMed ID: 4352867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological studies on the release of slow reacting substance of anaphylaxis during anti-immunoglobulin E antibody mediated passive peritoneal anaphylaxis in rats.
    Nagai H; Yamada H; Matsuura N; Iwamoto T; Choi SH; Koda A
    J Pharmacobiodyn; 1987 Jan; 10(1):49-54. PubMed ID: 3108486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of traxanox sodium on SRS-A release in bronchial and peritoneal anaphylaxis].
    Terasawa M; Imayoshi T; Goto K
    Nihon Yakurigaku Zasshi; 1983 Jul; 82(1):93-101. PubMed ID: 6194083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ro 22-3747: a new antiallergic agent for the treatment of immediate hypersensitivity diseases.
    Welton AF; Hope WC; O'Donnell M; Baruth H; Crowley HJ; Miller DA; Yaremko B
    J Pharmacol Exp Ther; 1984 Jan; 228(1):57-64. PubMed ID: 6198511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute systemic anaphylaxis in the calf.
    Eyre P; Lewis AJ; Wells PW
    Br J Pharmacol; 1973 Mar; 47(3):504-16. PubMed ID: 4147191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Release of mediators of anaphylaxis: inhibition of prostaglandin synthesis and the modification of release of slow reacting substance of anaphylaxis and histamine.
    Engineer DM; Niederhauser U; Piper PJ; Sirois P
    Br J Pharmacol; 1978 Jan; 62(1):61-6. PubMed ID: 74266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The inhibition by dexamethasone and disodium cromoglycate of anaphylactic bronchoconstriction in the rat.
    Church MK; Collier HO; James GW
    Br J Pharmacol; 1972 Sep; 46(1):56-65. PubMed ID: 4404396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The release of prostaglandins and thromboxanes from guinea-pig lung by slow reacting substance of anaphylaxis, and its inhibition.
    Engineer DM; Morris HR; Piper PJ; Sirois P
    Br J Pharmacol; 1978 Oct; 64(2):211-8. PubMed ID: 708991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritoneal anaphylaxis in the rat after sensitization with mouse antiserum.
    Spicer BA; Ross JW; Sharpe TJ; Smith H
    Int Arch Allergy Appl Immunol; 1978; 56(6):493-9. PubMed ID: 415988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel model of IgE-mediated passive pulmonary anaphylaxis in rats.
    Wex E; Thaler E; Blum S; Lamb D
    PLoS One; 2014; 9(12):e116166. PubMed ID: 25541997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of sodium 5,6-dimethyl-2-nitroindanedione on anaphylactic reactions in vitro.
    Sharpe TJ; Ross JW; Spicer BA
    Agents Actions; 1978 Apr; 8(3):199-202. PubMed ID: 78665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rat passive peritoneal anaphylaxis following sensitisation with guinea pig antiserum: an immediate hypersensitivity reaction without histamine release.
    Smith H; Ross JW; Spicer BA
    Int Arch Allergy Appl Immunol; 1980; 62(2):195-204. PubMed ID: 6154654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased vascular permeability during passive peritoneal anaphylaxis in the rat. The effects of disodium cromoglycate and a nitroindanedione.
    Ross JW; Smith H; Spicer BA
    Int Arch Allergy Appl Immunol; 1976; 51(2):226-37. PubMed ID: 58838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of ibudilast, a novel antiasthmatic agent, on anaphylactic bronchoconstriction: predominant involvement of endogenous slow reacting substance of anaphylaxis.
    Ohashi M; Uno T; Nishino K
    Int Arch Allergy Immunol; 1993; 101(3):288-96. PubMed ID: 8324390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response of rat lung to humoral mediators of anaphylaxis and its modification by drugs and sensitization.
    Church MK
    Br J Pharmacol; 1975 Nov; 55(3):423-30. PubMed ID: 1203628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
    Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B
    Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological analysis of the vascular permeability response in the anaphylactic phase of allergic inflammation in rats.
    Ohuchi K; Hirasawa N; Watanabe M; Tsurufuji S
    Eur J Pharmacol; 1985 Nov; 117(3):337-45. PubMed ID: 4076349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative bioactivity of histamine and slow reacting substance of anaphylaxis released during anaphylactic reaction from different tissues of guinea pigs and rats.
    Shahani SR; Dhar HL
    Indian J Physiol Pharmacol; 1987; 31(2):107-10. PubMed ID: 2444537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.